RRC ID 68959
著者 Ozawa T, Miyazono K, Morikawa M.
タイトル Preparation of monovalent follistatin-like 3-Fc-fusion protein and evaluation of its effects on muscle mass in mice.
ジャーナル STAR Protoc
Abstract Follistatin-like 3 (FSTL3) is an endogenous antagonist against transforming growth factor-β family ligands. Monovalent FSTL3-Fc fusion protein (mono-FSTL3-Fc) generated with knobs-into-holes technology overcomes limitations of current anti-myostatin therapies. We have developed a facile protocol for affinity purification of the Fc-fused protein from the supernatant of HEK293T cells stably expressing the protein. This protocol is advantageous by only requiring readily accessible equipment. We further outline the steps for validation of mono-FSTL3-Fc increasing systemic muscle mass in mice after intraperitoneal administration. For complete details on the use and execution of this protocol, please refer to Ozawa et al. (2021).
巻・号 2(4)
ページ 100839
公開日 2021-12-17
DOI 10.1016/j.xpro.2021.100839
PII S2666-1667(21)00545-1
PMID 34585166
PMC PMC8455479
MeSH Animals Follistatin* / metabolism Follistatin-Related Proteins* / genetics HEK293 Cells Humans Mice Muscles / metabolism Transforming Growth Factor beta / metabolism
リソース情報
遺伝子材料 CSII-EF-RfA (RDB04387)